General Information of Drug Off-Target (DOT) (ID: OT6482WN)

DOT Name Tandem C2 domains nuclear protein (TC2N)
Synonyms Membrane targeting tandem C2 domain-containing protein 1; Tandem C2 protein in nucleus; Tac2-N
Gene Name TC2N
Related Disease
Breast cancer ( )
Breast carcinoma ( )
Advanced cancer ( )
Lung cancer ( )
Lung carcinoma ( )
Neoplasm ( )
Venous thromboembolism ( )
Acute myelogenous leukaemia ( )
UniProt ID
TAC2N_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF00168
Sequence
MATEFIKSCCGGCFYGETEKHNFSVERDFKAAVPNSQNATISVPPLTSVSVKPQLGCTED
YLLSKLPSDGKEVPFVVPKFKLSYIQPRTQETPSHLEELEGSARASFGDRKVELSSSSQH
GPSYDVYNPFYMYQHISPDLSRRFPPRSEVKRLYGSVCDLRTNKLPGSPGLSKSMFDLTN
SSQRFIQRHDSLSSVPSSSSSRKNSQGSNRSLDTITLSGDERDFGRLNVKLFYNSSVEQI
WITVLQCRDLSWPSSYGDTPTVSIKGILTLPKPVHFKSSAKEGSNAIEFMETFVFAIKLQ
NLQTVRLVFKIQTQTPRKKTIGECSMSLRTLSTQEMDYSLDITPPSKISVCHAELELGTC
FQAVNSRIQLQILEARYLPSSSTPLTLSFFVKVGMFSSGELIYKKKTRLLKASNGRVKWG
ETMIFPLIQSEKEIVFLIKLYSRSSVRRKHFVGQIWISEDSNNIEAVNQWKETVINPEKV
VIRWHKLNPS

Molecular Interaction Atlas (MIA) of This DOT

8 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Breast cancer DIS7DPX1 Definitive Altered Expression [1]
Breast carcinoma DIS2UE88 Definitive Altered Expression [1]
Advanced cancer DISAT1Z9 Strong Biomarker [1]
Lung cancer DISCM4YA Strong Altered Expression [2]
Lung carcinoma DISTR26C Strong Altered Expression [2]
Neoplasm DISZKGEW Strong Altered Expression [1]
Venous thromboembolism DISUR7CR Strong Genetic Variation [3]
Acute myelogenous leukaemia DISCSPTN Limited Genetic Variation [4]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Tandem C2 domains nuclear protein (TC2N). [5]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Tandem C2 domains nuclear protein (TC2N). [7]
------------------------------------------------------------------------------------
7 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
SNDX-275 DMH7W9X Phase 3 SNDX-275 increases the expression of Tandem C2 domains nuclear protein (TC2N). [6]
Belinostat DM6OC53 Phase 2 Belinostat increases the expression of Tandem C2 domains nuclear protein (TC2N). [6]
(+)-JQ1 DM1CZSJ Phase 1 (+)-JQ1 decreases the expression of Tandem C2 domains nuclear protein (TC2N). [8]
Trichostatin A DM9C8NX Investigative Trichostatin A increases the expression of Tandem C2 domains nuclear protein (TC2N). [9]
Milchsaure DM462BT Investigative Milchsaure increases the expression of Tandem C2 domains nuclear protein (TC2N). [10]
Coumestrol DM40TBU Investigative Coumestrol decreases the expression of Tandem C2 domains nuclear protein (TC2N). [11]
Acetaldehyde DMJFKG4 Investigative Acetaldehyde decreases the expression of Tandem C2 domains nuclear protein (TC2N). [12]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Drug(s)

References

1 Identification of TC2N as a novel promising suppressor of PI3K-AKT signaling in breast cancer.Cell Death Dis. 2019 May 29;10(6):424. doi: 10.1038/s41419-019-1663-5.
2 TC2N, a novel oncogene, accelerates tumor progression by suppressing p53 signaling pathway in lung cancer.Cell Death Differ. 2019 Jul;26(7):1235-1250. doi: 10.1038/s41418-018-0202-8. Epub 2018 Sep 25.
3 Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism.Blood. 2019 Nov 7;134(19):1645-1657. doi: 10.1182/blood.2019000435.
4 Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia.Oncotarget. 2017 Jan 31;8(5):7891-7899. doi: 10.18632/oncotarget.13631.
5 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
6 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
7 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
8 Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells. J Biol Chem. 2012 Dec 14;287(51):43137-55.
9 From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol. 2014 Jul;88(7):1451-68.
10 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.
11 Pleiotropic combinatorial transcriptomes of human breast cancer cells exposed to mixtures of dietary phytoestrogens. Food Chem Toxicol. 2009 Apr;47(4):787-95.
12 Transcriptome profile analysis of saturated aliphatic aldehydes reveals carbon number-specific molecules involved in pulmonary toxicity. Chem Res Toxicol. 2014 Aug 18;27(8):1362-70.